Current Report Filing (8-k)
0001349706 false 0001349706 2022-09-20
2022-09-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
Date of Report (Date of earliest event
IMPERALIS HOLDING CORP.
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction of
incorporation or organization)
||(Commission File Number)
||(I.R.S. Employer Identification
1421 McCarthy Blvd.,
(Address of principal executive offices) (Zip Code)
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
Securities registered pursuant to Section 12(b) of the Act:
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
||Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers
On September 20, 2022, Darren M. Magot voluntarily resigned from
the Board of Directors (the “Board”) of Imperalis Holding
Corp. (the “Company”). Effective immediately upon Mr.
Magot’s resignation, Douglas Gintz, the Company’s Chief Technology
Officer, and Marcus Charuvastra, the Company’s President, were
appointed to serve on the Board.
Douglas Gintz has served as our Chief Technology
Officer since September 6, 2022. Prior thereto, he served as the
Chief Technology Officer of TurnOnGreen, Inc., since February 2021.
Mr. Gintz has over 30 years of hands-on experience bringing
products to market. Specializing in emerging technologies, Mr.
Gintz has developed manufacturing compliance systems, DNA reporting
engines, medical billing software, e-commerce applications, and
retail software for companies ranging from startups to
multinational corporations. Mr. Gintz also currently serves as the
Chief Technology Officer and Director of Global Technology
Implementation for the Parent since February 2021. Mr. Gintz's
previous leadership roles include Chief Executive Officer of
Pacific Coders, LLC. from August 2002 to January 2022; Chief
Technology Officer of Endocanna Health, Inc. from January 2019 to
January 2021; Mr. Gintz served at Targeted Medical Pharma, Inc., a
publicly-traded microcap, as Chief Marketing Officer and Technology
Officer from January 2018 to December 2019, and Chief Technology
Officer and Chief Information Officer from January 2012 to May
Marcus Charuvastra as served as our President since
September 6, 2022. Prior thereto, he served as the President of
TurnOnGreen, Inc., since January 2022 and previously served as its
Chief Revenue Officer since June 2021. Mr. Charuvastra is an
accomplished leader with 20 years of experience in strategic
planning, sales, services, marketing and business and
organizational development. Mr. Charuvastra spent nine years at
Targeted Medical Pharma, Inc. serving as Vice President of
Operations and as the Managing Director of this microcap biotech
start-up, from 2012 to May 2021. During his tenure, he was
instrumental in guiding Targeted Medical Pharma’s initial public
offering. Mr. Charuvastra was previously Director of Sales and
Marketing at Physician Therapeutics from 2009 to 2012 and was
responsible for building the sales and distribution network in the
United States and abroad. He is a graduate of University of
California Los Angeles.
Mr. Magot’s resignation was not the result of a disagreement
between Mr. Magot and the Company on any matter relating to the
Company’s operations, policies or practices.
There were no arrangements or understandings between the Company or
any other person and each of Messrs. Gintz and Charuvastra pursuant
to each of his appointment.
There have been no transactions between each of Messrs. Gintz and
Charuvastra and the Company other than those arising from his
employment agreement with the Company and no disclosure is required
under Item 404(a) of Regulation S-K.
||Financial Statements and
||Pursuant to Rule 406 of Regulation
S-T, the cover page is formatted in Inline XBRL (Inline eXtensible
Business Reporting Language).
||Cover Page Interactive Data File
(embedded within the Inline XBRL document and included in Exhibit
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
||IMPERALIS HOLDING CORP.
|Dated: September 20, 2022
Chief Executive Officer
Imperalis (PK) (USOTC:IMHC)
Historical Stock Chart
From Dec 2022 to Jan 2023
Imperalis (PK) (USOTC:IMHC)
Historical Stock Chart
From Jan 2022 to Jan 2023